| scholarly article | Q13442814 |
| P2093 | author name string | Jason T Blackard | |
| Nagako Akeno | |||
| Yaron Tomer | |||
| P2860 | cites work | The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease | Q45142894 |
| Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity | Q45411403 | ||
| Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells | Q45738814 | ||
| Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry | Q45754853 | ||
| Hepatitis C and thyroid autoimmunity: is there a link? | Q47311379 | ||
| Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease | Q47349199 | ||
| Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy | Q47841043 | ||
| By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse. | Q50718894 | ||
| Association of the TSHR gene with Graves' disease: the first disease specific locus. | Q50758182 | ||
| The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. | Q51757534 | ||
| The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. | Q54000430 | ||
| Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study | Q73454554 | ||
| Autoimmunity. The pathogen connection | Q74824330 | ||
| A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology | Q81441210 | ||
| Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. | Q22010245 | ||
| Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis | Q22010480 | ||
| Infection, thyroid disease, and autoimmunity | Q22306220 | ||
| The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future | Q24673258 | ||
| Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders | Q27472760 | ||
| Interferon Alpha Treatment and Thyroid Dysfunction | Q27483686 | ||
| Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein | Q27485143 | ||
| Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease | Q28201947 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells | Q33206994 | ||
| Hepatitis C and D, retroviruses and autoimmune manifestations | Q34239657 | ||
| Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals | Q34239681 | ||
| Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease | Q34391184 | ||
| Autoimmunity and hepatitis C | Q35556343 | ||
| Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity | Q35852892 | ||
| The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification | Q36430258 | ||
| Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences | Q36519154 | ||
| Hepatitis C virus entry: molecular biology and clinical implications | Q36581588 | ||
| The pathophysiology of HCV induced B-cell clonal disorders | Q36940189 | ||
| The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology | Q37051756 | ||
| A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. | Q38303947 | ||
| Hepatitis C and Human Immunodeficiency Virus Envelope Proteins Cooperatively Induce Hepatocytic Apoptosis via an Innocent Bystander Mechanism | Q39281648 | ||
| Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes | Q40245620 | ||
| Host cell responses induced by hepatitis C virus binding. | Q40275014 | ||
| Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. | Q40355507 | ||
| Infections and autoimmune endocrine disease | Q40511593 | ||
| CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease | Q40841269 | ||
| Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. | Q42990630 | ||
| High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy | Q43039089 | ||
| Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a | Q43039967 | ||
| Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes | Q43047968 | ||
| Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease | Q44804359 | ||
| Thyroid disorders in chronic hepatitis C. | Q44946879 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 339-44 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunity | |
| P478 | volume | 31 |
| Q47140391 | A preliminary analysis of hepatitis C virus in pancreatic islet cells. |
| Q26830844 | Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection |
| Q88881049 | Autoimmune reactions in the course of the hepatitis C virus (HCV) infection |
| Q36862264 | Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy |
| Q51823680 | Challenges for the autoimmunologist. |
| Q54974833 | Chronic urticaria and thyroid autoimmunity: a perplexing association. |
| Q35085745 | Cutting edge: the etiology of autoimmune thyroid diseases |
| Q59349480 | Endocrine disorders associated with hepatitis C virus chronic infection |
| Q37464862 | Environmental triggers of autoimmune thyroiditis |
| Q37836257 | Environmental triggers of thyroiditis: hepatitis C and interferon-α. |
| Q38254121 | Extrahepatic immune related manifestations in chronic hepatitis C virus infection |
| Q37086396 | Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways |
| Q38730457 | Hepatitis C Virus E2 Protein Induces Upregulation of IL-8 Pathways and Production of Heat Shock Proteins in Human Thyroid Cells |
| Q33716540 | Hepatitis C and interferon induced thyroiditis |
| Q38497354 | Hepatitis C virus and autoimmunity |
| Q38057221 | Hepatitis C virus infection and autoimmune diseases |
| Q26775018 | Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment |
| Q39222504 | Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. |
| Q37527686 | Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies |
| Q35020174 | IFN-α mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms. |
| Q33636049 | Interferon induced thyroiditis |
| Q38852548 | Molecular mimicry and autoimmune thyroid disease |
| Q64083565 | Non-specific impairment of Lung Function on Spirometery in Patients with Chronic Hepatitis-C |
| Q35213091 | Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. |
| Q52374882 | Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma. |
| Q36579326 | The etiology of autoimmune thyroid disease: a story of genes and environment |
| Q42574790 | The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study |
| Q33790643 | Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area. |
| Q33881738 | Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia |
| Q36285235 | Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan |
| Q43520862 | Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C. |
| Q42174926 | Thyroiditis, secondary to viral infection |
Search more.